Cresco Labs Inc. (CSE:CL)
1.020
-0.030 (-2.86%)
Aug 10, 2026, 11:50 AM EST
Cresco Labs Revenue
Cresco Labs had revenue of $173.34M USD in the quarter ending June 30, 2026, with 4.35% growth. This brings the company's revenue in the last twelve months to $648.64M, down -5.66% year-over-year. In the year 2025, Cresco Labs had annual revenue of $655.85M, down -9.46%.
Revenue (ttm)
$648.64M
Revenue Growth
-5.66%
P/S Ratio
0.42
Revenue / Employee
$223.67K
Employees
2,900
Market Cap
388.33M CAD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 655.85M | -68.50M | -9.46% |
| Dec 31, 2024 | 724.34M | -31.71M | -4.19% |
| Dec 31, 2023 | 756.06M | -68.87M | -8.35% |
| Dec 31, 2022 | 824.93M | 19.25M | 2.39% |
| Dec 31, 2021 | 805.68M | 342.60M | 73.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Verano Holdings | 1.19B |
| TerrAscend | 374.77M |
| Aurora Cannabis | 314.07M |
| Canopy Growth | 293.63M |
| Organigram Global | 274.19M |
| Auxly Cannabis Group | 158.57M |
| Medexus Pharmaceuticals | 138.65M |
| Cannara Biotech | 117.33M |
Cresco Labs News
- 3 days ago - Cresco Labs price target lowered to C$2.50 from C$3.25 at Alliance Global - TheFly
- 4 days ago - Cresco Labs Earnings Call Transcript: Q2 2026 - Transcripts
- 4 days ago - Cresco Labs Registration statement: Q2 2026 - Filings
- 4 days ago - Cresco Labs Registration statement: Q2 2026 - Filings
- 4 days ago - Cresco Labs Earnings release: Q2 2026 - Filings
- 4 days ago - Cresco Labs Slides: Q2 2026 - Filings
- 4 days ago - Cresco Labs Reports Second Quarter 2026 Financial Results; Delivers $173 Million in Revenue and $40 Million in Adjusted EBITDA - Business Wire
- 23 days ago - 2 Marijuana Stocks To Watch For Stronger Trading This Week - MarijuanaStocks